ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Herpes Labialis Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39R1477
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Herpes Labialis Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Herpes Labialis Drugs Market Research Report 2025

Code: QYRE-Auto-39R1477
Report
September 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Novartis
TEVA
Mylan NV
Cadila
Apotex
Daewoong Pharmaceutical
LIVZON
Med shine
Blistex
Hikma
Carmex
Cipher
Bayer

Herpes Labialis Drugs Market Size

The global market for Herpes Labialis Drugs was valued at US$ 2632 million in the year 2024 and is projected to reach a revised size of US$ 3315 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Herpes Labialis Drugs Market

Herpes Labialis Drugs Market

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Herpes Labialis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Labialis Drugs.
The Herpes Labialis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Herpes Labialis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Herpes Labialis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Herpes Labialis Drugs Market Report

Report Metric Details
Report Name Herpes Labialis Drugs Market
Accounted market size in year US$ 2632 million
Forecasted market size in 2031 US$ 3315 million
CAGR 3.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Valacyclovir
  • Aciclovir
  • Famciclovir
  • Docosanol
  • Other
Segment by Application
  • External Use
  • Oral
  • Injection
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon, Med Shine, Bayer, Blistex, Hikma, Carmex, Cipher
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Herpes Labialis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Herpes Labialis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Herpes Labialis Drugs Market growing?

Ans: The Herpes Labialis Drugs Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Herpes Labialis Drugs Market size in 2031?

Ans: The Herpes Labialis Drugs Market size in 2031 will be US$ 3315 million.

Who are the main players in the Herpes Labialis Drugs Market report?

Ans: The main players in the Herpes Labialis Drugs Market are GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon, Med Shine, Bayer, Blistex, Hikma, Carmex, Cipher

What are the Application segmentation covered in the Herpes Labialis Drugs Market report?

Ans: The Applications covered in the Herpes Labialis Drugs Market report are External Use, Oral, Injection

What are the Type segmentation covered in the Herpes Labialis Drugs Market report?

Ans: The Types covered in the Herpes Labialis Drugs Market report are Valacyclovir, Aciclovir, Famciclovir, Docosanol, Other

1 Herpes Labialis Drugs Market Overview
1.1 Product Definition
1.2 Herpes Labialis Drugs by Type
1.2.1 Global Herpes Labialis Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Valacyclovir
1.2.3 Aciclovir
1.2.4 Famciclovir
1.2.5 Docosanol
1.2.6 Other
1.3 Herpes Labialis Drugs by Application
1.3.1 Global Herpes Labialis Drugs Market Value by Application (2024 VS 2031)
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Global Herpes Labialis Drugs Market Size Estimates and Forecasts
1.4.1 Global Herpes Labialis Drugs Revenue 2020-2031
1.4.2 Global Herpes Labialis Drugs Sales 2020-2031
1.4.3 Global Herpes Labialis Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Herpes Labialis Drugs Market Competition by Manufacturers
2.1 Global Herpes Labialis Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Herpes Labialis Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Herpes Labialis Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Herpes Labialis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Herpes Labialis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Herpes Labialis Drugs, Product Type & Application
2.7 Global Key Manufacturers of Herpes Labialis Drugs, Date of Enter into This Industry
2.8 Global Herpes Labialis Drugs Market Competitive Situation and Trends
2.8.1 Global Herpes Labialis Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Herpes Labialis Drugs Players Market Share by Revenue
2.8.3 Global Herpes Labialis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Herpes Labialis Drugs Market Scenario by Region
3.1 Global Herpes Labialis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Herpes Labialis Drugs Sales by Region: 2020-2031
3.2.1 Global Herpes Labialis Drugs Sales by Region: 2020-2025
3.2.2 Global Herpes Labialis Drugs Sales by Region: 2026-2031
3.3 Global Herpes Labialis Drugs Revenue by Region: 2020-2031
3.3.1 Global Herpes Labialis Drugs Revenue by Region: 2020-2025
3.3.2 Global Herpes Labialis Drugs Revenue by Region: 2026-2031
3.4 North America Herpes Labialis Drugs Market Facts & Figures by Country
3.4.1 North America Herpes Labialis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Herpes Labialis Drugs Sales by Country (2020-2031)
3.4.3 North America Herpes Labialis Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Herpes Labialis Drugs Market Facts & Figures by Country
3.5.1 Europe Herpes Labialis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Herpes Labialis Drugs Sales by Country (2020-2031)
3.5.3 Europe Herpes Labialis Drugs Revenue by Country (2020-2031)
3.6 Asia Pacific Herpes Labialis Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Herpes Labialis Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Herpes Labialis Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Herpes Labialis Drugs Revenue by Region (2020-2031)
3.7 Latin America Herpes Labialis Drugs Market Facts & Figures by Country
3.7.1 Latin America Herpes Labialis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Herpes Labialis Drugs Sales by Country (2020-2031)
3.7.3 Latin America Herpes Labialis Drugs Revenue by Country (2020-2031)
3.8 Middle East and Africa Herpes Labialis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Herpes Labialis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Herpes Labialis Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Herpes Labialis Drugs Revenue by Country (2020-2031)
4 Segment by Type
4.1 Global Herpes Labialis Drugs Sales by Type (2020-2031)
4.1.1 Global Herpes Labialis Drugs Sales by Type (2020-2025)
4.1.2 Global Herpes Labialis Drugs Sales by Type (2026-2031)
4.1.3 Global Herpes Labialis Drugs Sales Market Share by Type (2020-2031)
4.2 Global Herpes Labialis Drugs Revenue by Type (2020-2031)
4.2.1 Global Herpes Labialis Drugs Revenue by Type (2020-2025)
4.2.2 Global Herpes Labialis Drugs Revenue by Type (2026-2031)
4.2.3 Global Herpes Labialis Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Herpes Labialis Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Herpes Labialis Drugs Sales by Application (2020-2031)
5.1.1 Global Herpes Labialis Drugs Sales by Application (2020-2025)
5.1.2 Global Herpes Labialis Drugs Sales by Application (2026-2031)
5.1.3 Global Herpes Labialis Drugs Sales Market Share by Application (2020-2031)
5.2 Global Herpes Labialis Drugs Revenue by Application (2020-2031)
5.2.1 Global Herpes Labialis Drugs Revenue by Application (2020-2025)
5.2.2 Global Herpes Labialis Drugs Revenue by Application (2026-2031)
5.2.3 Global Herpes Labialis Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Herpes Labialis Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Herpes Labialis Drugs Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Herpes Labialis Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Herpes Labialis Drugs Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Herpes Labialis Drugs Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Cadila
6.5.1 Cadila Company Information
6.5.2 Cadila Description and Business Overview
6.5.3 Cadila Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cadila Herpes Labialis Drugs Product Portfolio
6.5.5 Cadila Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Company Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Apotex Herpes Labialis Drugs Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Daewoong Pharmaceutical
6.7.1 Daewoong Pharmaceutical Company Information
6.7.2 Daewoong Pharmaceutical Description and Business Overview
6.7.3 Daewoong Pharmaceutical Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Daewoong Pharmaceutical Herpes Labialis Drugs Product Portfolio
6.7.5 Daewoong Pharmaceutical Recent Developments/Updates
6.8 Livzon
6.8.1 Livzon Company Information
6.8.2 Livzon Description and Business Overview
6.8.3 Livzon Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Livzon Herpes Labialis Drugs Product Portfolio
6.8.5 Livzon Recent Developments/Updates
6.9 Med Shine
6.9.1 Med Shine Company Information
6.9.2 Med Shine Description and Business Overview
6.9.3 Med Shine Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Med Shine Herpes Labialis Drugs Product Portfolio
6.9.5 Med Shine Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Company Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer Herpes Labialis Drugs Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Blistex
6.11.1 Blistex Company Information
6.11.2 Blistex Description and Business Overview
6.11.3 Blistex Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Blistex Herpes Labialis Drugs Product Portfolio
6.11.5 Blistex Recent Developments/Updates
6.12 Hikma
6.12.1 Hikma Company Information
6.12.2 Hikma Description and Business Overview
6.12.3 Hikma Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hikma Herpes Labialis Drugs Product Portfolio
6.12.5 Hikma Recent Developments/Updates
6.13 Carmex
6.13.1 Carmex Company Information
6.13.2 Carmex Description and Business Overview
6.13.3 Carmex Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Carmex Herpes Labialis Drugs Product Portfolio
6.13.5 Carmex Recent Developments/Updates
6.14 Cipher
6.14.1 Cipher Company Information
6.14.2 Cipher Description and Business Overview
6.14.3 Cipher Herpes Labialis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Cipher Herpes Labialis Drugs Product Portfolio
6.14.5 Cipher Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Herpes Labialis Drugs Industry Chain Analysis
7.2 Herpes Labialis Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Herpes Labialis Drugs Production Mode & Process Analysis
7.4 Herpes Labialis Drugs Sales and Marketing
7.4.1 Herpes Labialis Drugs Sales Channels
7.4.2 Herpes Labialis Drugs Distributors
7.5 Herpes Labialis Drugs Customer Analysis
8 Herpes Labialis Drugs Market Dynamics
8.1 Herpes Labialis Drugs Industry Trends
8.2 Herpes Labialis Drugs Market Drivers
8.3 Herpes Labialis Drugs Market Challenges
8.4 Herpes Labialis Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
Novartis
TEVA
Mylan NV
Cadila
Apotex
Daewoong Pharmaceutical
LIVZON
Med shine
Blistex
Hikma
Carmex
Cipher
Bayer
List of Tables
 Table 1. Global Herpes Labialis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Herpes Labialis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Herpes Labialis Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Herpes Labialis Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Herpes Labialis Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Herpes Labialis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Herpes Labialis Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Herpes Labialis Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Herpes Labialis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Herpes Labialis Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Herpes Labialis Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Herpes Labialis Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Herpes Labialis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Labialis Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Herpes Labialis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Herpes Labialis Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Herpes Labialis Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Herpes Labialis Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Herpes Labialis Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Herpes Labialis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Herpes Labialis Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Herpes Labialis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Herpes Labialis Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Herpes Labialis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Herpes Labialis Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Herpes Labialis Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Herpes Labialis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Herpes Labialis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Herpes Labialis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Herpes Labialis Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Herpes Labialis Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Herpes Labialis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Herpes Labialis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Herpes Labialis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Herpes Labialis Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Herpes Labialis Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Herpes Labialis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Herpes Labialis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Herpes Labialis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Herpes Labialis Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Herpes Labialis Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Herpes Labialis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Herpes Labialis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Herpes Labialis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Herpes Labialis Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Herpes Labialis Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Herpes Labialis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Herpes Labialis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Herpes Labialis Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Herpes Labialis Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Herpes Labialis Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Herpes Labialis Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Herpes Labialis Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Herpes Labialis Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Herpes Labialis Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Herpes Labialis Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Herpes Labialis Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Herpes Labialis Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Herpes Labialis Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Herpes Labialis Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Herpes Labialis Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Herpes Labialis Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Herpes Labialis Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Herpes Labialis Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Herpes Labialis Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Herpes Labialis Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Herpes Labialis Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Herpes Labialis Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. GSK Herpes Labialis Drugs Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Novartis Herpes Labialis Drugs Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Teva Herpes Labialis Drugs Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Mylan Company Information
 Table 86. Mylan Description and Business Overview
 Table 87. Mylan Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Mylan Herpes Labialis Drugs Product
 Table 89. Mylan Recent Developments/Updates
 Table 90. Cadila Company Information
 Table 91. Cadila Description and Business Overview
 Table 92. Cadila Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Cadila Herpes Labialis Drugs Product
 Table 94. Cadila Recent Developments/Updates
 Table 95. Apotex Company Information
 Table 96. Apotex Description and Business Overview
 Table 97. Apotex Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Apotex Herpes Labialis Drugs Product
 Table 99. Apotex Recent Developments/Updates
 Table 100. Daewoong Pharmaceutical Company Information
 Table 101. Daewoong Pharmaceutical Description and Business Overview
 Table 102. Daewoong Pharmaceutical Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Daewoong Pharmaceutical Herpes Labialis Drugs Product
 Table 104. Daewoong Pharmaceutical Recent Developments/Updates
 Table 105. Livzon Company Information
 Table 106. Livzon Description and Business Overview
 Table 107. Livzon Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Livzon Herpes Labialis Drugs Product
 Table 109. Livzon Recent Developments/Updates
 Table 110. Med Shine Company Information
 Table 111. Med Shine Description and Business Overview
 Table 112. Med Shine Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Med Shine Herpes Labialis Drugs Product
 Table 114. Med Shine Recent Developments/Updates
 Table 115. Bayer Company Information
 Table 116. Bayer Description and Business Overview
 Table 117. Bayer Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Bayer Herpes Labialis Drugs Product
 Table 119. Bayer Recent Developments/Updates
 Table 120. Blistex Company Information
 Table 121. Blistex Description and Business Overview
 Table 122. Blistex Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Blistex Herpes Labialis Drugs Product
 Table 124. Blistex Recent Developments/Updates
 Table 125. Hikma Company Information
 Table 126. Hikma Description and Business Overview
 Table 127. Hikma Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Hikma Herpes Labialis Drugs Product
 Table 129. Hikma Recent Developments/Updates
 Table 130. Carmex Company Information
 Table 131. Carmex Description and Business Overview
 Table 132. Carmex Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Carmex Herpes Labialis Drugs Product
 Table 134. Carmex Recent Developments/Updates
 Table 135. Cipher Company Information
 Table 136. Cipher Description and Business Overview
 Table 137. Cipher Herpes Labialis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Cipher Herpes Labialis Drugs Product
 Table 139. Cipher Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Herpes Labialis Drugs Distributors List
 Table 143. Herpes Labialis Drugs Customers List
 Table 144. Herpes Labialis Drugs Market Trends
 Table 145. Herpes Labialis Drugs Market Drivers
 Table 146. Herpes Labialis Drugs Market Challenges
 Table 147. Herpes Labialis Drugs Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Herpes Labialis Drugs
 Figure 2. Global Herpes Labialis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Herpes Labialis Drugs Market Share by Type: 2024 & 2031
 Figure 4. Valacyclovir Product Picture
 Figure 5. Aciclovir Product Picture
 Figure 6. Famciclovir Product Picture
 Figure 7. Docosanol Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Herpes Labialis Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Herpes Labialis Drugs Market Share by Application: 2024 & 2031
 Figure 11. External Use
 Figure 12. Oral
 Figure 13. Injection
 Figure 14. Global Herpes Labialis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Herpes Labialis Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Herpes Labialis Drugs Sales (2020-2031) & (K Pcs)
 Figure 17. Global Herpes Labialis Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Herpes Labialis Drugs Report Years Considered
 Figure 19. Herpes Labialis Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Herpes Labialis Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Herpes Labialis Drugs Players: Market Share by Revenue in Herpes Labialis Drugs in 2024
 Figure 22. Herpes Labialis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Herpes Labialis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Herpes Labialis Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Herpes Labialis Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Herpes Labialis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Herpes Labialis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Herpes Labialis Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Herpes Labialis Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Asia Pacific Herpes Labialis Drugs Sales Market Share by Region (2020-2031)
 Figure 31. Asia Pacific Herpes Labialis Drugs Revenue Market Share by Region (2020-2031)
 Figure 32. Latin America Herpes Labialis Drugs Sales Market Share by Country (2020-2031)
 Figure 33. Latin America Herpes Labialis Drugs Revenue Market Share by Country (2020-2031)
 Figure 34. Middle East and Africa Herpes Labialis Drugs Sales Market Share by Country (2020-2031)
 Figure 35. Middle East and Africa Herpes Labialis Drugs Revenue Market Share by Country (2020-2031)
 Figure 36. Global Sales Market Share of Herpes Labialis Drugs by Type (2020-2031)
 Figure 37. Global Revenue Market Share of Herpes Labialis Drugs by Type (2020-2031)
 Figure 38. Global Herpes Labialis Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 39. Global Sales Market Share of Herpes Labialis Drugs by Application (2020-2031)
 Figure 40. Global Revenue Market Share of Herpes Labialis Drugs by Application (2020-2031)
 Figure 41. Global Herpes Labialis Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 42. Herpes Labialis Drugs Value Chain
 Figure 43. Channels of Distribution (Direct Vs Distribution)
 Figure 44. Bottom-up and Top-down Approaches for This Report
 Figure 45. Data Triangulation
 Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Drugs for Herpes Labialis Oral Herpes Market Insights Forecast to 2030
Global Mouth Ulcer Treatment Drug Market Insights Forecast to 2030
Mouth Ulcers Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herpes Labialis Treatment Market Research Report 2024
Herpes Simplex Virus Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herpes Simplex Virus HSV Vaccines Market Insights Forecast to 2030
Drugs for Mouth Ulcer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genital Herpes Treatment Drugs Market Insights Forecast to 2030
Global Herpes Zoster Treatment Market Insights Forecast to 2030
Canker Sores Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Canker Sores Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cold Sore Treatment Device Market Research Report 2024
Global Drugs for Oral Mucositis Market Research Report 2024
Global Oral Mucositis Drugs Market Research Report 2025
Oral Mucositis Drugs for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Oral Mucositis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Angular Cheilitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mouth Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Herpes Simplex Keratitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mouth Sore Medicine Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions